TherapeuticsMD Inc.
TXMD | NASDAQ
$2.12
+$0.02 (+0.95%)
Sep 22, 2026, 1:27 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 7.48M | 5.06M | 4.33M | 38.07M | 64.91M | 80.49M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 16.01M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 14.16M | 2.46M | 18.54M | 20.51M | 33.8M | 253K |
Receivables | 3.53M | 3.56M | 3.09M | n/a | 36.18M | 32.38M |
Inventory | n/a | n/a | n/a | n/a | 7.62M | 7.99M |
Other Current Assets | 3.35M | 1.23M | 4.13M | 16.12M | 8.46M | 4.98M |
Total Current Assets | 14.45M | 9.93M | 11.8M | 55.35M | 119.47M | 128.4M |
Property-Plant & Equipment | 5.29M | 6.1M | 6.87M | 7.66M | 9.06M | 11.51M |
Goodwill & Intangibles | 3.76M | 4.32M | 6.1M | 6.94M | 7.14M | 41.45M |
Total Long-Term Assets | 23.21M | 28.9M | 31.51M | 35.11M | 50M | 53.21M |
Total Assets | 37.66M | 38.82M | 43.31M | 90.46M | 169.47M | 181.61M |
Account Payables | 377K | 258K | 27K | 2.16M | 3.37M | 21.07M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 1.63M | n/a | n/a | 188.27M | n/a |
Other Current Liabilities | 2.67M | 3.16M | 3.69M | 30.53M | 47.91M | 7.06M |
Total Current Liabilities | 4.79M | 5.17M | 6.85M | 46.84M | 252.89M | 59.24M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 237.7M |
Other Long-Term Liabilities | 873K | 744K | 636K | 1.11M | 2.14M | n/a |
Total Long-Term Liabilities | 6M | 6.29M | 7.17M | 8.48M | 10.2M | 246.37M |
Total Liabilities | 10.78M | 11.45M | 14.02M | 55.32M | 263.09M | 305.61M |
Total Debt | 6.1M | 7.18M | 8.01M | 8.76M | 197.69M | 248.63M |
Book Value | 26.88M | 27.37M | 29.29M | 35.14M | -93.62M | -124M |
Book Value Per Share | 2.32 | 2.37 | 2.80 | 3.89 | -11.76 | -22.49 |
Common Stock | 11K | 11K | 11K | 9K | 9K | 300K |
Retained Earnings | -952.39M | -951.82M | -949.64M | -939.36M | -1.05B | -878.95M |
Comprehensive Income | n/a | n/a | 0 | 0 | n/a | n/a |
Shareholders Equity | 26.88M | 27.37M | 29.29M | 35.14M | -93.62M | -124M |
Total Investments | n/a | 16.01M | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TXMD